CoChat
Sign Up
Cited by 186Endometriosis Research and TreatmentEstrogen and related hormone effectsInflammatory mediators and NSAID effects

The DOI matches its Crossref record; 11 of the 11 references it cites were found in a registry or an index.

Inflammatory Status Influences Aromatase and Steroid Receptor Expression in Endometriosis

Open access
Bukulmez, Orhan, Hardy, Daniel B., Carr, Bruce R., Word, R. Ann, Mendelson, Carole R.·2008·Endocrinology
DOI 10.1210/en.2007-0665PMC PMC2275353
Open this paper in CoChat — free account

Abstract

Aberrant up-regulation of aromatase in eutopic endometrium and implants from women with endometriosis has been reported. Aromatase induction may be mediated by increased cyclooxygenase-2 (COX-2). Recently, we demonstrated that progesterone receptor (PR)-A and PR-B serve an antiinflammatory role in the uterus by antagonizing nuclear factor kappaB activation and COX-2 expression. PR-C, which antagonizes PR-B, is up-regulated by inflammation. Although estrogen receptor alpha (ERalpha) is implicated in endometriosis, an antiinflammatory role of ERbeta has been suggested. We examined stage-specific expression of aromatase, COX-2, ER, and PR isoform expression in eutopic endometrium, implants, peritoneum, and endometrioma samples from endometriosis patients. Endometrial and peritoneal biopsies were obtained from unaffected women and those with fibroids. Aromatase expression in eutopic endometrium from endometriosis patients was significantly increased compared with controls. Aromatase expression in endometriosis implants was markedly increased compared with eutopic endometrium. Aromatase mRNA levels were increased significantly in red implants relative to black implants and endometrioma cyst capsule. Moreover, COX-2 expression was increased in implants and in eutopic endometrium of women with endometriosis as compared with control endometrium. As observed for aromatase mRNA, the highest levels of COX-2 mRNA were found in red implants. The ratio of ERbeta/ERalpha mRNA was significan…

Overview

Integrity signals

Registry

Crossref · 10.1210/en.2007-0665

Cites

0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Flagged first, then by citations

Show all 0 references

Research works printed but not linked: 96

  1. Kitawaki, 1997, Expression of aromatase cytochrome P450 protein and messenger ribonucleic acid in human endometriotic and adenomyotic tissues but not in normal endometrium., Biol Reprod, 57, 514, 10.1095/biolreprod57.3.514 · DOI · Paper page
  2. Bulun, 2001, Role of aromatase in endometrial disease., J Steroid Biochem Mol Biol, 79, 19, 10.1016/S0960-0760(01)00134-0 · DOI
  3. Yang, 2002, Regulation of aromatase P450 expression in endometriotic and endometrial stromal cells by CCAAT/enhancer binding proteins (C/EBPs): decreased C/EBPβ in endometriosis is associated with overexpression of aromatase., J Clin Endocrinol Metab, 87, 2336
  4. Lebovic, 2001, IL-1β induction of RANTES (regulated upon activation, normal T cell expressed and secreted) chemokine gene expression in endometriotic stromal cells depends on a nuclear factor-κB site in the proximal promoter., J Clin Endocrinol Metab, 86, 4759
  5. Fournet-Dulguerov, 1987, Immunohistochemical localization of aromatase cytochrome P-450 and estradiol dehydrogenase in the syncytiotrophoblast of the human placenta., J Clin Endocrinol Metab, 65, 757, 10.1210/jcem-65-4-757 · DOI
  6. Carreau, 2001, Germ cells: a new source of estrogens in the male gonad., Mol Cell Endocrinol, 178, 65, 10.1016/S0303-7207(01)00411-7 · DOI
  7. Roselli, 1998, Anatomic distribution and regulation of aromatase gene expression in the rat brain., Biol Reprod, 58, 79, 10.1095/biolreprod58.1.79 · DOI
  8. Simpson, 1997, Aromatase expression in health and disease., Recent Prog Horm Res, 52, 185
  9. Zhao, 1997, Transcriptional regulation of CYP19 gene (aromatase) expression in adipose stromal cells in primary culture., J Steroid Biochem Mol Biol, 61, 203, 10.1016/S0960-0760(97)80013-1 · DOI
  10. Brodie, 2001, Aromatase and COX-2 expression in human breast cancers., J Steroid Biochem Mol Biol, 79, 41, 10.1016/S0960-0760(01)00131-5 · DOI
  11. Simpson, 1993, Tissue-specific promoters regulate aromatase cytochrome P450 expression., J Steroid Biochem Mol Biol, 44, 321, 10.1016/0960-0760(93)90235-O · DOI
  12. Simpson, 1994, Aromatase cytochrome P450, the enzyme responsible for estrogen biosynthesis., Endocr Rev, 15, 342
  13. Zeitoun, 1999, Stimulation of aromatase P450 promoter (II) activity in endometriosis and its inhibition in endometrium are regulated by competitive binding of steroidogenic factor-1 and chicken ovalbumin upstream promoter transcription factor to the same cis-acting element., Mol Endocrinol, 13, 239, 10.1210/mend.13.2.0229 · DOI · Paper page
  14. Nilsson, 2001, Mechanisms of estrogen action., Physiol Rev, 81, 1535, 10.1152/physrev.2001.81.4.1535 · DOI
  15. Greene, 1986, Sequence and expression of human estrogen receptor complementary DNA., Science, 231, 1150, 10.1126/science.3753802 · DOI
  16. Kuiper, 1996, Cloning of a novel receptor expressed in rat prostate and ovary., Proc Natl Acad Sci USA, 93, 5925, 10.1073/pnas.93.12.5925 · DOI
  17. Harris, 2006, The unexpected science of estrogen receptor-β selective agonists: a new class of anti-inflammatory agents?, Nucl Recept Signal, 4, e012, 10.1621/nrs.04012 · DOI
  18. Xing, 2007, Estrogen modulates TNF-α-induced inflammatory responses in rat aortic smooth muscle cells through estrogen receptor-β activation, Am J Physiol Heart Circ Physiol, 292, H2566, 10.1152/ajpheart.01107.2006 · DOI
  19. Matsuzaki, 2000, Characterization of messenger RNA expression of estrogen receptor-α and -β in patients with ovarian endometriosis., Fertil Steril, 73, 1219, 10.1016/S0015-0282(00)00527-6 · DOI
  20. Horwitz, 1985, Hormone-dependent covalent modification and processing of human progesterone receptors in the nucleus., DNA, 4, 451, 10.1089/dna.1985.4.451 · DOI
  21. Wei, 1990, 5′-Heterogeneity in human progesterone receptor transcripts predicts a new amino-terminal truncated “C”-receptor and unique A-receptor messages., Mol Endocrinol, 4, 1833, 10.1210/mend-4-12-1833 · DOI
  22. Vegeto, 1993, Human progesterone receptor A form is a cell- and promoter-specific repressor of human progesterone receptor B function., Mol Endocrinol, 7, 1244
  23. Fertil Steril, 67, 817, 10.1016/S0015-0282(97)81391-X · DOI · Paper page
  24. Mote, 2001, Detection of progesterone receptor forms A and B by immunohistochemical analysis., J Clin Pathol, 54, 624, 10.1136/jcp.54.8.624 · DOI
  25. Goldman, 2005, Progesterone receptor expression in human decidua and fetal membranes before and after contractions: possible mechanism for functional progesterone withdrawal., Mol Hum Reprod, 11, 269, 10.1093/molehr/gah161 · DOI
  26. Oh, 2005, Progesterone receptor isoform (A/B) ratio of human fetal membranes increases during term parturition., Am J Obstet Gynecol, 193, 1156, 10.1016/j.ajog.2005.05.071 · DOI
  27. Chomczynski, 1987, Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction., Anal Biochem, 162, 156, 10.1016/0003-2697(87)90021-2 · DOI
  28. Mesiano, 2002, Progesterone withdrawal and estrogen activation in human parturition are coordinated by progesterone receptor A expression in the myometrium., J Clin Endocrinol Metab, 87, 2924, 10.1210/jcem.87.6.8609 · DOI
  29. Mendelson, 2006, Role of the progesterone receptor (PR) in the regulation of inflammatory response pathways and aromatase in the breast., J Steroid Biochem Mol Biol, 102, 241, 10.1016/j.jsbmb.2006.09.029 · DOI
  30. Ishibashi, 2003, Sex steroid hormone receptors in human thymoma., J Clin Endocrinol Metab, 88, 2309, 10.1210/jc.2002-021353 · DOI
  31. Aerts, 2002, Evaluation of progesterone receptor expression in eosinophils using real-time quantitative PCR., Biochim Biophys Acta, 1571, 167, 10.1016/S0304-4165(02)00192-7 · DOI
  32. Blough, 1999, Extraction of nuclear proteins from striated muscle tissue., Biotechniques, 26, 202, 10.2144/99262bm05 · DOI
  33. Fazleabas, 2003, Steroid receptor and aromatase expression in baboon endometriotic lesions, Fertil Steril, 80, 820, 10.1016/S0015-0282(03)00982-8 · DOI
  34. Thomas, 1995, Endometriosis, 1995—confusion or sense?, Int J Gynaecol Obstet, 48, 149, 10.1016/0020-7292(94)02277-6 · DOI
  35. Batzer, 2006, GnRH analogs: options for endometriosis-associated pain treatment., J Minim Invasive Gynecol, 13, 539, 10.1016/j.jmig.2006.07.007 · DOI · Paper page
  36. Olive, 2002, The treatment of endometriosis: a review of the evidence., Ann NY Acad Sci, 955, 360, 10.1111/j.1749-6632.2002.tb02797.x · DOI
  37. Brandenberger, 1999, Oestrogen receptor (ER)-α and ER-β isoforms in normal endometrial and endometriosis-derived stromal cells., Mol Hum Reprod, 5, 651, 10.1093/molehr/5.7.651 · DOI · Paper page
  38. Zarmakoupis, 1995, Inhibition of human endometrial stromal cell proliferation by interleukin 6., Hum Reprod, 10, 2395, 10.1093/oxfordjournals.humrep.a136306 · DOI
  39. Sumitani, 2000, In situ estrogen synthesized by aromatase P450 in uterine leiomyoma cells promotes cell growth probably via an autocrine/intracrine mechanism., Endocrinology, 141, 3852, 10.1210/endo.141.10.7719 · DOI
  40. Yamaki, 1985, Aromatization of androstenedione by normal and neoplastic endometrium of the uterus., J Steroid Biochem, 22, 63, 10.1016/0022-4731(85)90142-6 · DOI
  41. Hill, 1989, Lymphocyte activity in the presence of peritoneal fluid from fertile women and infertile women with and without endometriosis., Am J Obstet Gynecol, 161, 861, 10.1016/0002-9378(89)90736-9 · DOI
  42. Koike, 1992, Correlation between dysmenorrheic severity and prostaglandin production in women with endometriosis., Prostaglandins Leukot Essent Fatty Acids, 46, 133, 10.1016/0952-3278(92)90219-9 · DOI
  43. De Leon, 1988, Prostaglandin F2α and E2 release by peritoneum with and without endometriosis., Int J Fertil, 33, 48
  44. Ota, 2001, Distribution of cyclooxygenase-2 in eutopic and ectopic endometrium in endometriosis and adenomyosis., Hum Reprod, 16, 561, 10.1093/humrep/16.3.561 · DOI
  45. Tamura, 2002, Interleukin-1β elevates cyclooxygenase-2 protein level and enzyme activity via increasing its mRNA stability in human endometrial stromal cells: an effect mediated by extracellularly regulated kinases 1 and 2., J Clin Endocrinol Metab, 87, 3263
  46. Tamura, 2002, Up-regulation of cyclooxygenase-2 expression and prostaglandin synthesis in endometrial stromal cells by malignant endometrial epithelial cells. A paracrine effect mediated by prostaglandin E2 and nuclear factor-κB., J Biol Chem, 277, 26208, 10.1074/jbc.M201347200 · DOI
  47. Bulun, 2000, Estrogen biosynthesis in endometriosis: molecular basis and clinical relevance., J Mol Endocrinol, 25, 35, 10.1677/jme.0.0250035 · DOI
  48. Hardy, 2006, Progesterone receptor plays a major antiinflammatory role in human myometrial cells by antagonism of nuclear factor-κB activation of cyclooxygenase 2 expression., Mol Endocrinol, 20, 2724, 10.1210/me.2006-0112 · DOI
  49. Yue, 1998, In situ aromatization enhances breast tumor estradiol levels and cellular proliferation., Cancer Res, 58, 927
  50. Bulun, 1994, Expression of the CYP19 gene and its product aromatase cytochrome P450 in human uterine leiomyoma tissues and cells in culture., J Clin Endocrinol Metab, 78, 736
  51. Paech, 1997, Differential ligand activation of estrogen receptors ERα and ERβ at AP1 sites., Science, 277, 1508, 10.1126/science.277.5331.1508 · DOI · Paper page
  52. Saville, 2000, Ligand-, cell-, and estrogen receptor subtype (α/β)-dependent activation at GC-rich (Sp1) promoter elements., J Biol Chem, 275, 5379, 10.1074/jbc.275.8.5379 · DOI
  53. Harris, 2007, Estrogen receptor-β: recent lessons from in vivo studies., Mol Endocrinol, 21, 1, 10.1210/me.2005-0459 · DOI
  54. Evans, 2002, Estrogen receptors α and β have similar activities in multiple endothelial cell pathways., Endocrinology, 143, 3785, 10.1210/en.2002-220356 · DOI
  55. Tyree, 2002, 17β-Estradiol inhibits cytokine induction of the human E-selectin promoter., J Steroid Biochem Mol Biol, 80, 291, 10.1016/S0960-0760(02)00022-5 · DOI
  56. Mukherjee, 2003, 17-Epiestriol, an estrogen metabolite, is more potent than estradiol in inhibiting vascular cell adhesion molecule 1 (VCAM-1) mRNA expression., J Biol Chem, 278, 11746, 10.1074/jbc.M207800200 · DOI
  57. Caulin-Glaser, 1996, Effects of 17β-estradiol on cytokine-induced endothelial cell adhesion molecule expression., J Clin Invest, 98, 36, 10.1172/JCI118774 · DOI
  58. Cuzzocrea, 2001, The protective role of endogenous estrogens in carrageenan-induced lung injury in the rat., Mol Med, 7, 478, 10.1007/BF03401853 · DOI
  59. Evans, 2002, Estrogen receptor α inhibits IL-1β induction of gene expression in the mouse liver., Endocrinology, 143, 2559, 10.1210/endo.143.7.8919 · DOI
  60. Miyamoto, 1999, Estrogen protects against cellular infiltration by reducing the expressions of E-selectin and IL-6 in endotoxin-induced uveitis., J Immunol, 163, 374, 10.4049/jimmunol.163.1.374 · DOI
  61. Hodgin, 2002, Minireview: estrogen and mouse models of atherosclerosis., Endocrinology, 143, 4495, 10.1210/en.2002-220844 · DOI
  62. Jansson, 2001, Enhancement of collagen-induced arthritis in female mice by estrogen receptor blockage., Arthritis Rheum, 44, 2168, 10.1002/1529-0131(200109)44:9<2168::AID-ART370>3.0.CO;2-2 · DOI
  63. Harnish, 2004, Beneficial effects of estrogen treatment in the HLA-B27 transgenic rat model of inflammatory bowel disease, Am J Physiol Gastrointest Liver Physiol, 286, G118, 10.1152/ajpgi.00024.2003 · DOI
  64. Stein, 1995, Repression of the interleukin-6 promoter by estrogen receptor is mediated by NF-κB and C/EBP β., Mol Cell Biol, 15, 4971, 10.1128/MCB.15.9.4971 · DOI
  65. Ray, 1994, Down-modulation of interleukin-6 gene expression by 17β-estradiol in the absence of high affinity DNA binding by the estrogen receptor., J Biol Chem, 269, 12940, 10.1016/S0021-9258(18)99966-7 · DOI
  66. Ray, 1997, Repression of interleukin-6 gene expression by 17β-estradiol: inhibition of the DNA-binding activity of the transcription factors NF-IL6 and NF-κB by the estrogen receptor., FEBS Lett, 409, 79, 10.1016/S0014-5793(97)00487-0 · DOI
  67. Deshpande, 1997, Estradiol down-regulates LPS-induced cytokine production and NFkB activation in murine macrophages., Am J Reprod Immunol, 38, 46, 10.1111/j.1600-0897.1997.tb00275.x · DOI
  68. Sun, 1998, Estrogen inhibits phorbol ester-induced IκBα transcription and protein degradation., Biochem Biophys Res Commun, 244, 691, 10.1006/bbrc.1998.8324 · DOI
  69. Harnish, 2000, The role of CBP in estrogen receptor cross-talk with nuclear factor-κB in HepG2 cells., Endocrinology, 141, 3403, 10.1210/endo.141.9.7646 · DOI
  70. Speir, 2000, Competition for p300 regulates transcription by estrogen receptors and nuclear factor-κB in human coronary smooth muscle cells., Circ Res, 87, 1006, 10.1161/01.RES.87.11.1006 · DOI
  71. Liu, 2002, Opposing action of estrogen receptors α and β on cyclin D1 gene expression., J Biol Chem, 277, 24353, 10.1074/jbc.M201829200 · DOI
  72. Lindberg, 2003, Estrogen receptor (ER)-β reduces ERα-regulated gene transcription, supporting a “ying yang” relationship between ERα and ERβ in mice., Mol Endocrinol, 17, 203, 10.1210/me.2002-0206 · DOI
  73. Weihua, 2000, Estrogen receptor (ER) β, a modulator of ERα in the uterus., Proc Natl Acad Sci USA, 97, 5936, 10.1073/pnas.97.11.5936 · DOI · Paper page
  74. Sahlin, 2006, Tissue- and hormone-dependent progesterone receptor distribution in the rat uterus., Reprod Biol Endocrinol, 4, 47, 10.1186/1477-7827-4-47 · DOI
  75. Kurita, 2001, Regulation of progesterone receptors and decidualization in uterine stroma of the estrogen receptor-α knockout mouse., Biol Reprod, 64, 272, 10.1095/biolreprod64.1.272 · DOI
  76. Cooke, 1997, Stromal estrogen receptors mediate mitogenic effects of estradiol on uterine epithelium., Proc Natl Acad Sci USA, 94, 6535, 10.1073/pnas.94.12.6535 · DOI
  77. Harris, 2005, A selective estrogen receptor-β agonist causes lesion regression in an experimentally induced model of endometriosis., Hum Reprod, 20, 936, 10.1093/humrep/deh711 · DOI
  78. Harris, 2003, Evaluation of an estrogen receptor-β agonist in animal models of human disease., Endocrinology, 144, 4241, 10.1210/en.2003-0550 · DOI
  79. Cowley, 1997, Estrogen receptors α and β form heterodimers on DNA., J Biol Chem, 272, 19858, 10.1074/jbc.272.32.19858 · DOI
  80. Kalita, 2005, Non-nuclear estrogen receptor β and α in the hippocampus of male and female rats., Hippocampus, 15, 404, 10.1002/hipo.20066 · DOI
  81. Monje, 2001, Subcellular distribution of native estrogen receptor α and β isoforms in rabbit uterus and ovary., J Cell Biochem, 82, 467, 10.1002/jcb.1182 · DOI
  82. Yang, 2004, Mitochondrial localization of estrogen receptor β., Proc Natl Acad Sci USA, 101, 4130, 10.1073/pnas.0306948101 · DOI
  83. Lu, 2004, Colocalization and alteration of estrogen receptor-α and -β in the hippocampus in Alzheimer’s disease., Hum Pathol, 35, 275, 10.1016/j.humpath.2003.11.004 · DOI
  84. Condon, 2006, Up-regulation of the progesterone receptor (PR)-C isoform in laboring myometrium by activation of nuclear factor-κB may contribute to the onset of labor through inhibition of PR function., Mol Endocrinol, 20, 764, 10.1210/me.2005-0242 · DOI
  85. Wei, 1996, An amino-terminal truncated progesterone receptor isoform, PRc, enhances progestin-induced transcriptional activity., Mol Endocrinol, 10, 1379
  86. Wei, 1997, An N-terminally truncated third progesterone receptor protein, PR(C), forms heterodimers with PR(B) but interferes in PR(B)-DNA binding., J Steroid Biochem Mol Biol, 62, 287, 10.1016/S0960-0760(97)00044-7 · DOI
  87. Andersson, 1997, Physiology and molecular genetics of 17β-hydroxysteroid dehydrogenases., Steroids, 62, 143, 10.1016/S0039-128X(96)00173-0 · DOI
  88. Chalbos, 1994, Differential effect of forms A and B of human progesterone receptor on estradiol-dependent transcription., J Biol Chem, 269, 23007, 10.1016/S0021-9258(17)31611-3 · DOI
  89. Mulac-Jericevic, 2003, Defective mammary gland morphogenesis in mice lacking the progesterone receptor B isoform., Proc Natl Acad Sci USA, 100, 9744, 10.1073/pnas.1732707100 · DOI
  90. Mote, 1999, Colocalization of progesterone receptors A and B by dual immunofluorescent histochemistry in human endometrium during the menstrual cycle., J Clin Endocrinol Metab, 84, 2963
  91. Jacobsen, 2005, Progesterone-independent effects of human progesterone receptors (PRs) in estrogen receptor-positive breast cancer: PR isoform-specific gene regulation and tumor biology., Mol Endocrinol, 19, 574, 10.1210/me.2004-0287 · DOI
  92. Hachisuga, 2002, Histopathological analysis of laparoscopically treated ovarian endometriotic cysts with special reference to loss of follicles., Hum Reprod, 17, 432, 10.1093/humrep/17.2.432 · DOI
  93. Reese, 1996, Endometriosis in an adolescent population: the Emory experience., J Pediatr Adolesc Gynecol, 9, 125, 10.1016/S1083-3188(96)70021-9 · DOI
  94. Davis, 1993, Clinical characteristics of adolescent endometriosis., J Adolesc Health, 14, 362, 10.1016/S1054-139X(08)80008-0 · DOI
  95. Donnez, 1998, Vascular endothelial growth factor (VEGF) in endometriosis., Hum Reprod, 13, 1686, 10.1093/humrep/13.6.1686 · DOI · Paper page
  96. Shifren, 1996, Ovarian steroid regulation of vascular endothelial growth factor in the human endometrium: implications for angiogenesis during the menstrual cycle and in the pathogenesis of endometriosis., J Clin Endocrinol Metab, 81, 3112

Cited by

Sorted by citations

Metadata

Authors
Bukulmez, O., Hardy, D. B., Carr, B. R., Word, R. A., & Mendelson, C. R.
Affiliations
  • Departments of Obstetrics and Gynecology (O.B., B.R.C., R.A.W., C.R.M.), The University of Texas Southwestern Medical Center at Dallas, Dallas, Texas 75390
  • The University of Texas Southwestern Medical Center (US)
Corresponding author
Mendelson, Carole R.
ORCID
Venue
Endocrinology
Publisher
The Endocrine Society
Published
2007-11-29
Volume
149
Issue
3
Pages
1190-1204
ISSN
  • 0013-7227 (ISSN-L)
  • 1945-7170
DOI
10.1210/en.2007-0665
PMC
PMC2275353
OpenAlex
W2052591056
Cited by
186
References
0
Citations by year
2026: 3 · 2025: 5 · 2024: 4 · 2023: 9 · 2022: 4 · 2021: 9 · 2020: 8 · 2019: 10 · 2018: 12 · 2017: 11 · 2016: 10 · 2015: 11 · 2014: 15 · 2013: 10 · 2012: 12
FWCI
15.10
Type
journal article
Language
en
Open access
Locations
  • Endocrinology (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Funders
National Institute of Diabetes and Digestive and Kidney Diseases (R01DK031206, DK31206)
Topics
  • Health Sciences › Medicine › Reproductive Medicine › Endometriosis Research and Treatment
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Endocrinology › Estrogen and related hormone effects
  • Health Sciences › Medicine › Pharmacology (medical) › Inflammatory mediators and NSAID effects
Keywords
endometriosis, aromatase, cyclooxygenase-2, progesterone receptor isoforms, estrogen receptor alpha, estrogen receptor beta, endometrioma, eutopic endometrium, inflammation, NF-κB, disease progression
MeSH terms
Adult, Aromatase, Cross-Sectional Studies, Endometriosis, Endometrium, Female, Humans, Inflammation, Ovary, Peritoneum, Prospective Studies, Receptors, Estrogen, Receptors, Progesterone, RNA, Messenger, Up-Regulation, Case-Control Studies, Protein Isoforms, Estrogen Receptor alpha, Estrogen Receptor beta, Cyclooxygenase 2

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review